Project Grant HT94252510308
Award Date
4/1/25
Completion Date
4/30/29
Dollars Obligated
$2.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37232, USA
Similar Awards
The U.S. Department of the Army Medical Command awarded a $2,264,623 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Vanderbilt University Medical Center (VUMC) to investigate "Toxicant-Mediated Pulmonary Hypertension in Southwest Asia Veterans." The award will fund research focused on transforming healthcare for military service members and the public, with a performance period from May 1, 2025 to April 30, 2029. VUMC, a prominent academic...
The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
The federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a $1,126,946 research initiative aimed at cardiovascular risk profiling of deployment-related respiratory diseases. The grant was awarded on November 1, 2024 to the Veterans Bio-Medical Research Institute, Inc., a non-profit research organization located in East Orange, New Jersey. This translational research project investigates innovative...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $525,000 Project Grant to Vanderbilt University Medical Center to investigate novel mechanisms of ovarian cancer initiation in the fallopian tube. The award, effective April 1, 2024 through March 31, 2026, supports biomedical research aimed at improving the health and care of military service members, veterans, and their families. As a sub-award under this grant, Vanderbilt University's...
This $750,000 federal Project Grant award from the Department of Defense's Defense Health Agency supports research by Vanderbilt University Medical Center (VUMC) on small RNAs and the heterogeneity of risk for developing systemic lupus erythematosus. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research related to military medicine. VUMC, a leading academic medical center and nonprofit healthcare provider, will...
Vanderbilt University Medical Center was awarded a $1,727,296 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from February 15, 2022 to February 14, 2025 to assess the role of intracellular parathyroid hormone-related protein signaling in mechanisms of tumor dormancy. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
The Department of the Army Medical Command awarded a $782,955.27 Project Grant to Vanderbilt University Medical Center on September 15, 2022, with a completion date of September 14, 2025. The grant supports research under the Military Medical Research and Development program (CFDA 12.420) to modulate lung and bone microenvironments to treat breast cancer metastases. The program aims to transform military and public health through innovative biomedical research solutions for battlefield...
The Department of the Army Medical Command awarded Vanderbilt University a $1.6 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support research into Modulation of Lung and Bone Microenvironments to Treat Breast Metastases. The three-year award beginning September 15, 2022 will fund investigation into medical solutions for breast cancer that has metastasized to the lungs and bones. As part of the Military Medical Research and Development...
This $345,800 Project Grant was awarded on May 1, 2024 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts. The grant supports research on the "Role of Stress Granules in the Pathogenesis and Therapy of Pulmonary Hypertension", with a performance period from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program funds a...